|
|
||||
| Public Act 095-0239 |
||||
| ||||
| ||||
AN ACT concerning criminal law.
| ||||
Be it enacted by the People of the State of Illinois,
| ||||
represented in the General Assembly:
| ||||
Section 5. The Illinois Controlled Substances Act is | ||||
amended by changing Section 204 as follows:
| ||||
(720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
| ||||
Sec. 204. (a) The controlled substances listed in this | ||||
Section are
included in Schedule I.
| ||||
(b) Unless specifically excepted or unless listed in | ||||
another
schedule, any of the following opiates, including their | ||||
isomers,
esters, ethers, salts, and salts of isomers, esters, | ||||
and ethers,
whenever the existence of such isomers, esters, | ||||
ethers and salts is
possible within the specific chemical | ||||
designation:
| ||||
(1) Acetylmethadol;
| ||||
(1.1) Acetyl-alpha-methylfentanyl
| ||||
(N-[1-(1-methyl-2-phenethyl)-
| ||||
4-piperidinyl]-N-phenylacetamide);
| ||||
(2) Allylprodine;
| ||||
(3) Alphacetylmethadol, except
| ||||
levo-alphacetylmethadol (also known as levo-alpha-
| ||||
acetylmethadol, levomethadyl acetate, or LAAM);
| ||||
(4) Alphameprodine;
| ||||
(5) Alphamethadol;
| ||
(6) Alpha-methylfentanyl
| ||
(N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
| ||
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
| ||
propanilido) piperidine;
| ||
(6.1) Alpha-methylthiofentanyl
| ||
(N-[1-methyl-2-(2-thienyl)ethyl-
| ||
4-piperidinyl]-N-phenylpropanamide);
| ||
(7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
| ||
(7) 1-methyl-4-phenyl-4-proprionoxypiperidine (MPPP);
| ||
(7.1) PEPAP
| ||
(1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
| ||
(8) Benzethidine;
| ||
(9) Betacetylmethadol;
| ||
(9.1) Beta-hydroxyfentanyl
| ||
(N-[1-(2-hydroxy-2-phenethyl)-
| ||
4-piperidinyl]-N-phenylpropanamide);
| ||
(10) Betameprodine;
| ||
(11) Betamethadol;
| ||
(12) Betaprodine;
| ||
(13) Clonitazene;
| ||
(14) Dextromoramide;
| ||
(15) Diampromide;
| ||
(16) Diethylthiambutene;
| ||
(17) Difenoxin;
| ||
(18) Dimenoxadol;
| ||
(19) Dimepheptanol;
| ||
(20) Dimethylthiambutene;
| ||
(21) Dioxaphetylbutyrate;
| ||
(22) Dipipanone;
| ||
(23) Ethylmethylthiambutene;
| ||
(24) Etonitazene;
| ||
(25) Etoxeridine;
| ||
(26) Furethidine;
| ||
(27) Hydroxpethidine;
| ||
(28) Ketobemidone;
| ||
(29) Levomoramide;
| ||
(30) Levophenacylmorphan;
| ||
(31) 3-Methylfentanyl
| ||
(N-[3-methyl-1-(2-phenylethyl)-
| ||
4-piperidyl]-N-phenylpropanamide);
| ||
(31.1) 3-Methylthiofentanyl
| ||
(N-[(3-methyl-1-(2-thienyl)ethyl-
| ||
4-piperidinyl]-N-phenylpropanamide);
| ||
(32) Morpheridine;
| ||
(33) Noracymethadol;
| ||
(34) Norlevorphanol;
| ||
(35) Normethadone;
| ||
(36) Norpipanone;
| ||
(36.1) Para-fluorofentanyl
| ||
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
| ||
4-piperidinyl]propanamide);
| ||
(37) Phenadoxone;
| ||
(38) Phenampromide;
| ||
(39) Phenomorphan;
| ||
(40) Phenoperidine;
| ||
(41) Piritramide;
| ||
(42) Proheptazine;
| ||
(43) Properidine;
| ||
(44) Propiram;
| ||
(45) Racemoramide;
| ||
(45.1) Thiofentanyl
| ||
(N-phenyl-N-[1-(2-thienyl)ethyl-
| ||
4-piperidinyl]-propanamide);
| ||
(46) Tilidine;
| ||
(47) Trimeperidine;
| ||
(48) Beta-hydroxy-3-methylfentanyl (other name:
| ||
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
| ||
N-phenylpropanamide).
| ||
(c) Unless specifically excepted or unless listed in | ||
another
schedule, any of the following opium derivatives, its | ||
salts, isomers
and salts of isomers, whenever the existence of | ||
such salts, isomers and
salts of isomers is possible within the | ||
specific chemical designation:
| ||
(1) Acetorphine;
| ||
(2) Acetyldihydrocodeine;
| ||
(3) Benzylmorphine;
| ||
(4) Codeine methylbromide;
| ||
(5) Codeine-N-Oxide;
| ||
(6) Cyprenorphine;
| ||
(7) Desomorphine;
| ||
(8) Diacetyldihydromorphine (Dihydroheroin);
| ||
(9) Dihydromorphine;
| ||
(10) Drotebanol;
| ||
(11) Etorphine (except hydrochloride salt);
| ||
(12) Heroin;
| ||
(13) Hydromorphinol;
| ||
(14) Methyldesorphine;
| ||
(15) Methyldihydromorphine;
| ||
(16) Morphine methylbromide;
| ||
(17) Morphine methylsulfonate;
| ||
(18) Morphine-N-Oxide;
| ||
(19) Myrophine;
| ||
(20) Nicocodeine;
| ||
(21) Nicomorphine;
| ||
(22) Normorphine;
| ||
(23) Pholcodine;
| ||
(24) Thebacon.
| ||
(d) Unless specifically excepted or unless listed in | ||
another
schedule, any material, compound, mixture, or | ||
preparation which contains
any quantity of the following | ||
hallucinogenic substances, or which
contains any of its salts, | ||
isomers and salts of isomers, whenever the
existence of such | ||
salts, isomers, and salts of isomers is possible
within the | ||
specific chemical designation (for the purposes of this
| ||
paragraph only, the term "isomer" includes the optical, | ||
position and
geometric isomers):
| ||
(1) 3,4-methylenedioxyamphetamine
| ||
(alpha-methyl,3,4-methylenedioxyphenethylamine,
| ||
methylenedioxyamphetamine, MDA);
| ||
(1.1) Alpha-ethyltryptamine
| ||
(some trade or other names: etryptamine;
| ||
MONASE; alpha-ethyl-1H-indole-3-ethanamine;
| ||
3-(2-aminobutyl)indole; a-ET; and AET);
| ||
(2) 3,4-methylenedioxymethamphetamine (MDMA);
| ||
(2.1) 3,4-methylenedioxy-N-ethylamphetamine
| ||
(also known as: N-ethyl-alpha-methyl-
| ||
3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
| ||
and MDEA);
| ||
(3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
| ||
(4) 3,4,5-trimethoxyamphetamine (TMA);
| ||
(5) (Blank);
| ||
(6) Diethyltryptamine (DET);
| ||
(7) Dimethyltryptamine (DMT);
| ||
(8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
| ||
(9) Ibogaine (some trade and other names:
| ||
7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
| ||
6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
| ||
indole; Tabernanthe iboga);
| ||
(10) Lysergic acid diethylamide;
| ||
(10.5) Salvia divinorum (meaning all parts of the plant | ||
presently classified
botanically as Salvia divinorum, | ||
whether growing or not, the
seeds thereof, any extract from | ||
any part of that plant, and every compound,
manufacture, | ||
salts, isomers, and salts of
isomers whenever the existence | ||
of such salts, isomers, and salts of
isomers is possible | ||
within the specific chemical designation, derivative, | ||
mixture, or preparation of that plant, its
seeds or | ||
extracts);
| ||
(11) 3,4,5-trimethoxyphenethylamine (Mescaline);
| ||
(12) Peyote (meaning all parts of the plant presently | ||
classified
botanically as Lophophora williamsii
williemaii
| ||
Lemaire, whether growing or not, the
seeds thereof, any | ||
extract from any part of that plant, and every compound,
| ||
manufacture, salts, derivative, mixture, or preparation of | ||
that plant, its
seeds or extracts);
| ||
(13) N-ethyl-3-piperidyl benzilate (JB 318);
| ||
(14) N-methyl-3-piperidyl benzilate;
| ||
(14.1) N-hydroxy-3,4-methylenedioxyamphetamine
| ||
(also known as N-hydroxy-alpha-methyl-
| ||
3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
| ||
(15) Parahexyl; some trade or other names:
| ||
3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
| ||
dibenzo (b,d) pyran; Synhexyl;
| ||
(16) Psilocybin;
| ||
(17) Psilocyn;
| ||
(18) Alpha-methyltryptamine (AMT);
| ||
(19) 2,5-dimethoxyamphetamine
| ||
(2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
| ||
(20) 4-bromo-2,5-dimethoxyamphetamine
| ||
(4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
| ||
4-bromo-2,5-DMA);
| ||
(20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
| ||
Some trade or other names: 2-(4-bromo-
| ||
2,5-dimethoxyphenyl)-1-aminoethane;
| ||
alpha-desmethyl DOB, 2CB, Nexus;
| ||
(21) 4-methoxyamphetamine
| ||
(4-methoxy-alpha-methylphenethylamine;
| ||
paramethoxyamphetamine; PMA);
| ||
(22) (Blank);
| ||
(23) Ethylamine analog of phencyclidine.
| ||
Some trade or other names:
| ||
N-ethyl-1-phenylcyclohexylamine,
| ||
(1-phenylcyclohexyl) ethylamine,
| ||
N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
| ||
(24) Pyrrolidine analog of phencyclidine. Some trade | ||
or other names:
1-(1-phenylcyclohexyl) pyrrolidine, PCPy, | ||
PHP;
| ||
(25) 5-methoxy-3,4-methylenedioxy-amphetamine;
| ||
(26) 2,5-dimethoxy-4-ethylamphetamine
| ||
(another name: DOET);
| ||
(27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
| ||
(another name: TCPy);
| ||
(28) (Blank);
| ||
(29) Thiophene analog of phencyclidine (some trade
| ||
or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
| ||
2-thienyl analog of phencyclidine; TPCP; TCP);
| ||
(30) Bufotenine (some trade or other names:
| ||
3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
| ||
3-(2-dimethylaminoethyl)-5-indolol;
| ||
5-hydroxy-N,N-dimethyltryptamine;
| ||
N,N-dimethylserotonin; mappine).
| ||
(e) Unless specifically excepted or unless listed in | ||
another
schedule, any material, compound, mixture, or | ||
preparation which contains
any quantity of the following | ||
substances having a depressant effect on
the central nervous | ||
system, including its salts, isomers, and salts of
isomers | ||
whenever the existence of such salts, isomers, and salts of
| ||
isomers is possible within the specific chemical designation:
| ||
(1) mecloqualone;
| ||
(2) methaqualone; and
| ||
(3) gamma hydroxybutyric acid.
| ||
(f) Unless specifically excepted or unless listed in | ||
another schedule,
any material, compound, mixture, or | ||
preparation which contains any quantity
of the following | ||
substances having a stimulant effect on the central nervous
| ||
system, including its salts, isomers, and salts of isomers:
| ||
(1) Fenethylline;
| ||
(2) N-ethylamphetamine;
| ||
(3) Aminorex (some other names:
| ||
2-amino-5-phenyl-2-oxazoline; aminoxaphen;
| ||
4-5-dihydro-5-phenyl-2-oxazolamine) and its
| ||
salts, optical isomers, and salts of optical isomers;
| ||
(4) Methcathinone (some other names:
| ||
2-methylamino-1-phenylpropan-1-one;
| ||
Ephedrone; 2-(methylamino)-propiophenone;
| ||
alpha-(methylamino)propiophenone; N-methylcathinone;
| ||
methycathinone; Monomethylpropion; UR 1431) and its
| ||
salts, optical isomers, and salts of optical isomers;
| ||
(5) Cathinone (some trade or other names:
| ||
2-aminopropiophenone; alpha-aminopropiophenone;
| ||
2-amino-1-phenyl-propanone; norephedrone);
| ||
(6) N,N-dimethylamphetamine (also known as:
| ||
N,N-alpha-trimethyl-benzeneethanamine;
| ||
N,N-alpha-trimethylphenethylamine);
| ||
(7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
| ||
4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
| ||
(g) Temporary listing of substances subject to emergency | ||
scheduling.
Any material, compound, mixture, or preparation | ||
that contains any quantity
of the following substances:
| ||
(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
| ||
(benzylfentanyl), its optical isomers, isomers, salts,
| ||
and salts of isomers;
| ||
(2) N-[1(2-thienyl)
| ||
methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
| ||
its optical isomers, salts, and salts of isomers.
| ||
(Source: P.A. 90-382, eff. 8-15-97; 91-714, eff. 6-2-00; | ||
revised 10-18-05.)
| ||